| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Peroxide | 26 | 2024 | 740 | 6.810 |
Why?
|
| Nitric Oxide Synthase Type III | 49 | 2024 | 706 | 5.600 |
Why?
|
| Nitric Oxide Synthase | 68 | 2019 | 911 | 5.000 |
Why?
|
| Endothelium, Vascular | 66 | 2022 | 4427 | 3.730 |
Why?
|
| Nitric Oxide | 41 | 2024 | 2146 | 3.230 |
Why?
|
| Oxidative Stress | 17 | 2024 | 3140 | 2.440 |
Why?
|
| rac1 GTP-Binding Protein | 8 | 2024 | 246 | 2.350 |
Why?
|
| Endothelial Cells | 20 | 2022 | 3589 | 2.180 |
Why?
|
| Lysophospholipids | 12 | 2013 | 338 | 1.990 |
Why?
|
| Caveolins | 14 | 2010 | 102 | 1.980 |
Why?
|
| Sphingosine | 11 | 2013 | 308 | 1.860 |
Why?
|
| Myocytes, Cardiac | 9 | 2022 | 1681 | 1.820 |
Why?
|
| Signal Transduction | 45 | 2024 | 23642 | 1.690 |
Why?
|
| Cattle | 46 | 2014 | 3819 | 1.680 |
Why?
|
| Oxidation-Reduction | 13 | 2024 | 2227 | 1.580 |
Why?
|
| Amino Acid Oxidoreductases | 19 | 1995 | 149 | 1.480 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2022 | 843 | 1.380 |
Why?
|
| Enzyme Activation | 28 | 2019 | 3587 | 1.370 |
Why?
|
| AMP-Activated Protein Kinases | 7 | 2020 | 593 | 1.160 |
Why?
|
| Phosphorylation | 38 | 2024 | 8314 | 1.150 |
Why?
|
| Adenosine Diphosphate | 4 | 2014 | 422 | 1.130 |
Why?
|
| Nitroglycerin | 3 | 2015 | 332 | 1.010 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 2149 | 0.900 |
Why?
|
| Aorta | 16 | 2015 | 2045 | 0.850 |
Why?
|
| Caveolin 1 | 13 | 2014 | 255 | 0.840 |
Why?
|
| Calmodulin | 8 | 2010 | 241 | 0.830 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 82 | 0.810 |
Why?
|
| Vasodilator Agents | 3 | 2015 | 990 | 0.780 |
Why?
|
| Membrane Proteins | 18 | 2016 | 7876 | 0.770 |
Why?
|
| Simvastatin | 3 | 2022 | 346 | 0.760 |
Why?
|
| Cells, Cultured | 51 | 2021 | 19017 | 0.760 |
Why?
|
| Animals | 124 | 2024 | 169222 | 0.730 |
Why?
|
| RNA, Small Interfering | 13 | 2014 | 3428 | 0.720 |
Why?
|
| Heart Failure | 5 | 2024 | 11883 | 0.710 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 2889 | 0.700 |
Why?
|
| Caveolae | 3 | 2012 | 54 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2012 | 1168 | 0.670 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2019 | 26 | 0.660 |
Why?
|
| Molecular Imaging | 2 | 2019 | 827 | 0.660 |
Why?
|
| Oxidants | 4 | 2021 | 168 | 0.650 |
Why?
|
| Receptors, Cell Surface | 9 | 2005 | 2819 | 0.650 |
Why?
|
| Biosensing Techniques | 4 | 2019 | 662 | 0.610 |
Why?
|
| Amino Acids | 5 | 2024 | 1716 | 0.570 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 428 | 0.530 |
Why?
|
| Receptors, Bradykinin | 3 | 2001 | 19 | 0.530 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2011 | 175 | 0.530 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 751 | 0.500 |
Why?
|
| Insulin | 7 | 2017 | 6606 | 0.500 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 18344 | 0.500 |
Why?
|
| Immunoblotting | 10 | 2014 | 1647 | 0.500 |
Why?
|
| Vasoconstriction | 2 | 2009 | 592 | 0.490 |
Why?
|
| Transfection | 21 | 2009 | 5757 | 0.490 |
Why?
|
| Myocardial Contraction | 9 | 2011 | 1525 | 0.490 |
Why?
|
| Fungal Proteins | 1 | 2019 | 906 | 0.480 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2016 | 123 | 0.480 |
Why?
|
| Immediate-Early Proteins | 3 | 2003 | 444 | 0.470 |
Why?
|
| Cardiomegaly | 3 | 2023 | 591 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 10 | 2016 | 1966 | 0.470 |
Why?
|
| Myocardium | 13 | 2012 | 4788 | 0.460 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2003 | 1247 | 0.450 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2014 | 40 | 0.450 |
Why?
|
| Arginine | 6 | 2013 | 932 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2017 | 2456 | 0.450 |
Why?
|
| Homoarginine | 1 | 2013 | 9 | 0.450 |
Why?
|
| Amidinotransferases | 1 | 2013 | 11 | 0.450 |
Why?
|
| Cell Movement | 9 | 2024 | 5209 | 0.440 |
Why?
|
| Bradykinin | 5 | 2001 | 205 | 0.440 |
Why?
|
| Palmitic Acid | 6 | 2002 | 149 | 0.440 |
Why?
|
| Calcium | 9 | 2019 | 5794 | 0.440 |
Why?
|
| Tetrazoles | 1 | 2019 | 923 | 0.430 |
Why?
|
| Angiotensin II | 3 | 2015 | 842 | 0.430 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3251 | 0.420 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 2 | 2009 | 30 | 0.410 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 671 | 0.390 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 163 | 0.380 |
Why?
|
| Lymphokines | 3 | 2003 | 924 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2009 | 2884 | 0.370 |
Why?
|
| Gene Knockdown Techniques | 4 | 2024 | 1605 | 0.370 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2007 | 514 | 0.350 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2014 | 494 | 0.350 |
Why?
|
| Mice | 35 | 2024 | 82024 | 0.330 |
Why?
|
| Epinephrine | 9 | 2007 | 793 | 0.330 |
Why?
|
| COS Cells | 10 | 2003 | 1135 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 10 | 2022 | 3514 | 0.320 |
Why?
|
| Sulfhydryl Compounds | 2 | 2009 | 296 | 0.320 |
Why?
|
| GTP Cyclohydrolase | 1 | 2009 | 46 | 0.320 |
Why?
|
| Capillary Permeability | 1 | 2012 | 772 | 0.310 |
Why?
|
| Nucleotides, Cyclic | 1 | 2009 | 83 | 0.310 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2005 | 1683 | 0.310 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2009 | 133 | 0.310 |
Why?
|
| Acylation | 8 | 2010 | 98 | 0.310 |
Why?
|
| Myristic Acids | 7 | 1998 | 49 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1244 | 0.290 |
Why?
|
| Cell Compartmentation | 6 | 1998 | 383 | 0.290 |
Why?
|
| Thiolester Hydrolases | 3 | 2013 | 91 | 0.290 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2007 | 63 | 0.290 |
Why?
|
| Enzyme Inhibitors | 8 | 2009 | 3726 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1120 | 0.280 |
Why?
|
| Microfilament Proteins | 2 | 2009 | 1133 | 0.280 |
Why?
|
| Recombinant Proteins | 12 | 2006 | 6515 | 0.280 |
Why?
|
| Metabolome | 1 | 2014 | 1009 | 0.270 |
Why?
|
| Neuropeptides | 1 | 2012 | 951 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2016 | 1495 | 0.270 |
Why?
|
| Vasodilation | 3 | 2015 | 968 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 1613 | 0.260 |
Why?
|
| Muscle Tonus | 2 | 2003 | 82 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 547 | 0.260 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 94 | 0.260 |
Why?
|
| Phosphoproteins | 3 | 2009 | 2450 | 0.260 |
Why?
|
| Autophagy | 1 | 2014 | 1349 | 0.250 |
Why?
|
| Down-Regulation | 4 | 2020 | 2936 | 0.250 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 434 | 0.250 |
Why?
|
| Dependovirus | 2 | 2022 | 720 | 0.250 |
Why?
|
| Cyclic GMP | 7 | 2009 | 394 | 0.240 |
Why?
|
| Protein Isoforms | 3 | 2022 | 1715 | 0.240 |
Why?
|
| Myristic Acid | 7 | 2002 | 49 | 0.240 |
Why?
|
| Rats, Wistar | 2 | 2019 | 1888 | 0.240 |
Why?
|
| Mice, Knockout | 13 | 2016 | 14486 | 0.230 |
Why?
|
| Nitrogen | 1 | 2005 | 345 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2011 | 10757 | 0.230 |
Why?
|
| Palmitic Acids | 4 | 1998 | 53 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta | 7 | 2009 | 243 | 0.220 |
Why?
|
| Isoenzymes | 7 | 2006 | 1688 | 0.220 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 664 | 0.220 |
Why?
|
| Calcium Signaling | 2 | 2007 | 739 | 0.210 |
Why?
|
| Receptors, Adrenergic | 8 | 1992 | 155 | 0.210 |
Why?
|
| Receptors, Growth Factor | 2 | 2003 | 324 | 0.210 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 118 | 0.210 |
Why?
|
| Catalase | 2 | 2014 | 215 | 0.210 |
Why?
|
| Molecular Sequence Data | 19 | 2016 | 17617 | 0.210 |
Why?
|
| Cyclosporine | 2 | 2002 | 777 | 0.200 |
Why?
|
| Androstadienes | 4 | 2007 | 348 | 0.200 |
Why?
|
| Adrenergic beta-Agonists | 5 | 2011 | 347 | 0.200 |
Why?
|
| Endothelium | 3 | 2008 | 768 | 0.200 |
Why?
|
| Heart Ventricles | 6 | 2013 | 3841 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 560 | 0.200 |
Why?
|
| Glutathione | 3 | 2019 | 589 | 0.200 |
Why?
|
| Animals, Newborn | 3 | 2024 | 2678 | 0.200 |
Why?
|
| Cell Line | 14 | 2014 | 15597 | 0.190 |
Why?
|
| Base Sequence | 14 | 2005 | 12418 | 0.190 |
Why?
|
| Rats | 20 | 2022 | 23751 | 0.190 |
Why?
|
| Receptors, Adrenergic, alpha | 7 | 1984 | 146 | 0.190 |
Why?
|
| Heart | 4 | 2010 | 4444 | 0.190 |
Why?
|
| Serine | 5 | 2009 | 831 | 0.190 |
Why?
|
| Cytosol | 3 | 2019 | 887 | 0.190 |
Why?
|
| Physical Therapy Modalities | 3 | 1995 | 533 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 327 | 0.180 |
Why?
|
| Biological Phenomena | 1 | 2021 | 28 | 0.180 |
Why?
|
| Ataxia | 1 | 2023 | 307 | 0.180 |
Why?
|
| Histamine | 1 | 2022 | 496 | 0.180 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 2414 | 0.180 |
Why?
|
| Cloning, Molecular | 7 | 1998 | 4168 | 0.180 |
Why?
|
| Isoproterenol | 6 | 2011 | 398 | 0.180 |
Why?
|
| Humans | 71 | 2024 | 767991 | 0.180 |
Why?
|
| Alanine | 2 | 2022 | 614 | 0.170 |
Why?
|
| Angina Pectoris | 2 | 2015 | 957 | 0.170 |
Why?
|
| Receptors, Lysosphingolipid | 3 | 2013 | 123 | 0.170 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 1999 | 17 | 0.170 |
Why?
|
| Spodoptera | 4 | 2006 | 140 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2018 | 3740 | 0.170 |
Why?
|
| Kinetics | 12 | 2009 | 6328 | 0.170 |
Why?
|
| Cyclic AMP | 5 | 2011 | 1471 | 0.160 |
Why?
|
| Amino Acid Sequence | 15 | 2016 | 13420 | 0.160 |
Why?
|
| Anaphylaxis | 1 | 2006 | 755 | 0.160 |
Why?
|
| Precipitin Tests | 4 | 2002 | 816 | 0.160 |
Why?
|
| Carbachol | 4 | 1998 | 223 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2634 | 0.160 |
Why?
|
| Heart Rate | 4 | 2009 | 4215 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 3108 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.150 |
Why?
|
| Ceramides | 1 | 1999 | 203 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 482 | 0.150 |
Why?
|
| Stereotyping | 1 | 2000 | 241 | 0.150 |
Why?
|
| Sirtuins | 1 | 2021 | 322 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1989 | 0.150 |
Why?
|
| Receptors, Lysophospholipid | 3 | 2003 | 40 | 0.150 |
Why?
|
| Protein Binding | 8 | 2007 | 9343 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 236 | 0.150 |
Why?
|
| Blood Platelets | 9 | 2016 | 2479 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 5694 | 0.150 |
Why?
|
| Occupations | 1 | 2000 | 516 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 1998 | 1494 | 0.140 |
Why?
|
| Fluorescent Dyes | 4 | 2013 | 1930 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 2061 | 0.140 |
Why?
|
| Genetic Vectors | 3 | 2019 | 3402 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 1377 | 0.140 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2015 | 4289 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 748 | 0.130 |
Why?
|
| Diabetic Angiopathies | 1 | 2001 | 806 | 0.130 |
Why?
|
| Neprilysin | 1 | 2019 | 487 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1656 | 0.130 |
Why?
|
| GTP-Binding Proteins | 6 | 1999 | 948 | 0.130 |
Why?
|
| Alexander Disease | 1 | 2015 | 15 | 0.130 |
Why?
|
| Proteins | 2 | 2009 | 6009 | 0.130 |
Why?
|
| Teaching Rounds | 1 | 2020 | 282 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 1972 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 9556 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 737 | 0.120 |
Why?
|
| Actin-Related Protein 2-3 Complex | 2 | 2016 | 61 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5887 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5798 | 0.120 |
Why?
|
| Baculoviridae | 1 | 1995 | 115 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 206 | 0.120 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2015 | 94 | 0.120 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 160 | 0.110 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 301 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 4525 | 0.110 |
Why?
|
| Troponin T | 1 | 2019 | 787 | 0.110 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2014 | 40 | 0.110 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1026 | 0.110 |
Why?
|
| Thrombopoiesis | 1 | 2016 | 166 | 0.110 |
Why?
|
| Cell Membrane | 10 | 2000 | 3657 | 0.110 |
Why?
|
| Plasmids | 3 | 2005 | 2269 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2019 | 2908 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1994 | 310 | 0.110 |
Why?
|
| Biological Transport | 6 | 1999 | 2085 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 563 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2005 | 474 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 2004 | 1252 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1104 | 0.110 |
Why?
|
| DNA Primers | 5 | 2004 | 2827 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 1998 | 707 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 478 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12252 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1515 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1065 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 1369 | 0.110 |
Why?
|
| Multigene Family | 2 | 1997 | 1081 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2014 | 415 | 0.110 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 7612 | 0.110 |
Why?
|
| Pyloric Stenosis | 1 | 1992 | 28 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2019 | 2089 | 0.100 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 259 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2015 | 714 | 0.100 |
Why?
|
| Homeostasis | 4 | 2021 | 3348 | 0.100 |
Why?
|
| Fatty Acids | 3 | 2008 | 1811 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 1243 | 0.100 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 90 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 201 | 0.100 |
Why?
|
| Methionine | 1 | 2015 | 573 | 0.100 |
Why?
|
| Methylene Blue | 1 | 1993 | 156 | 0.100 |
Why?
|
| Receptors, Muscarinic | 3 | 1998 | 156 | 0.100 |
Why?
|
| Nifedipine | 1 | 2012 | 221 | 0.100 |
Why?
|
| Actins | 2 | 2013 | 2064 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1993 | 239 | 0.100 |
Why?
|
| Stroke | 2 | 2013 | 9755 | 0.100 |
Why?
|
| Subcellular Fractions | 3 | 2004 | 526 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2012 | 145 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1281 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 703 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2011 | 219 | 0.090 |
Why?
|
| Megakaryocytes | 1 | 2016 | 571 | 0.090 |
Why?
|
| Hypertension | 3 | 2020 | 8616 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2014 | 373 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2011 | 103 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1674 | 0.090 |
Why?
|
| Lipase | 1 | 2013 | 321 | 0.090 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 244 | 0.090 |
Why?
|
| Time Factors | 7 | 2010 | 40214 | 0.090 |
Why?
|
| Guanylate Cyclase | 3 | 2009 | 206 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2010 | 88 | 0.090 |
Why?
|
| RNA, Messenger | 6 | 2005 | 12797 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2016 | 1110 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4146 | 0.090 |
Why?
|
| Nitrosation | 2 | 2007 | 25 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 839 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3912 | 0.090 |
Why?
|
| Glutathione Reductase | 1 | 2009 | 25 | 0.090 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2000 | 24 | 0.090 |
Why?
|
| Phosphorus Radioisotopes | 2 | 2002 | 100 | 0.090 |
Why?
|
| Saphenous Vein | 3 | 2003 | 519 | 0.090 |
Why?
|
| Casein Kinase II | 2 | 2016 | 121 | 0.090 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2009 | 25 | 0.090 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2009 | 32 | 0.090 |
Why?
|
| Naphthalimides | 1 | 2009 | 22 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 694 | 0.080 |
Why?
|
| Interferon-gamma | 3 | 1995 | 3159 | 0.080 |
Why?
|
| Genes | 1 | 1994 | 1824 | 0.080 |
Why?
|
| Lentivirus | 1 | 2013 | 518 | 0.080 |
Why?
|
| Thionucleotides | 1 | 2009 | 107 | 0.080 |
Why?
|
| Consensus Sequence | 3 | 1996 | 363 | 0.080 |
Why?
|
| Electrochemistry | 1 | 2009 | 145 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2009 | 56 | 0.080 |
Why?
|
| Streptokinase | 1 | 1989 | 186 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 626 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2473 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2014 | 795 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 688 | 0.080 |
Why?
|
| Heart Failure, Diastolic | 1 | 2010 | 77 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1992 | 312 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 1743 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15660 | 0.080 |
Why?
|
| Terpenes | 1 | 2009 | 102 | 0.080 |
Why?
|
| Copper | 1 | 2011 | 368 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 180 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 682 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2015 | 2766 | 0.080 |
Why?
|
| Aldehyde-Lyases | 1 | 2008 | 12 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| Liver | 5 | 2016 | 7574 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 2003 | 1550 | 0.070 |
Why?
|
| Guanylyl Imidodiphosphate | 5 | 1984 | 37 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 7 | 2004 | 6071 | 0.070 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2007 | 1 | 0.070 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 213 | 0.070 |
Why?
|
| Pertussis Toxin | 3 | 2005 | 176 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1162 | 0.070 |
Why?
|
| Astrocytes | 1 | 2015 | 1351 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 656 | 0.070 |
Why?
|
| Models, Biological | 5 | 2013 | 9493 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 212 | 0.070 |
Why?
|
| Disulfides | 1 | 2009 | 466 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1179 | 0.070 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 422 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 651 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2015 | 8540 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 350 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 644 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1963 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 1196 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3941 | 0.070 |
Why?
|
| Coronary Disease | 2 | 2010 | 5919 | 0.070 |
Why?
|
| Protein Kinases | 2 | 2005 | 1610 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 622 | 0.060 |
Why?
|
| Phosphates | 2 | 2002 | 765 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 414 | 0.060 |
Why?
|
| Embolism | 1 | 1989 | 401 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 492 | 0.060 |
Why?
|
| Apoptosis | 2 | 2019 | 9521 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 485 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 1676 | 0.060 |
Why?
|
| Male | 22 | 2019 | 364641 | 0.060 |
Why?
|
| Cardiology | 1 | 2016 | 1702 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 861 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 13000 | 0.060 |
Why?
|
| Virus Replication | 1 | 2013 | 2458 | 0.060 |
Why?
|
| DNA | 6 | 1993 | 7213 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2020 | 3463 | 0.060 |
Why?
|
| Acetylation | 1 | 2007 | 1055 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22381 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2009 | 863 | 0.060 |
Why?
|
| Yohimbine | 3 | 1992 | 62 | 0.060 |
Why?
|
| Arteries | 1 | 2009 | 1127 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 505 | 0.060 |
Why?
|
| Prostaglandins E | 2 | 1982 | 166 | 0.060 |
Why?
|
| Cardiolipins | 1 | 2023 | 82 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2024 | 26420 | 0.050 |
Why?
|
| Guanosine Triphosphate | 3 | 1982 | 315 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 1983 | 157 | 0.050 |
Why?
|
| Phosphopeptides | 2 | 1996 | 240 | 0.050 |
Why?
|
| Marine Toxins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2002 | 67 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 205 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2015 | 5024 | 0.050 |
Why?
|
| Calcium Channels | 2 | 1998 | 623 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1145 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 122 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 1951 | 0.050 |
Why?
|
| Organ Preservation Solutions | 1 | 2003 | 104 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1752 | 0.050 |
Why?
|
| CHO Cells | 2 | 1996 | 1379 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2120 | 0.050 |
Why?
|
| Cricetinae | 3 | 1996 | 2423 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Caveolin 3 | 2 | 1998 | 24 | 0.050 |
Why?
|
| Tritium | 3 | 1996 | 707 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 768 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 273 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2002 | 78 | 0.050 |
Why?
|
| Mitochondria | 2 | 2014 | 3681 | 0.050 |
Why?
|
| Albumins | 1 | 2004 | 577 | 0.050 |
Why?
|
| Mutagenesis | 2 | 1995 | 1228 | 0.050 |
Why?
|
| Oxazoles | 1 | 2002 | 199 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 265 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4937 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1997 | 3055 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 1980 | 55 | 0.050 |
Why?
|
| Luminescence | 1 | 2001 | 108 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 525 | 0.050 |
Why?
|
| Cystatins | 1 | 2000 | 55 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2011 | 2028 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 231 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1524 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2008 | 2001 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 298 | 0.040 |
Why?
|
| Muscarinic Agonists | 2 | 1998 | 91 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 839 | 0.040 |
Why?
|
| Sequence Alignment | 3 | 1998 | 2178 | 0.040 |
Why?
|
| Citrulline | 3 | 1995 | 107 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1901 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 1904 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 205 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1179 | 0.040 |
Why?
|
| Superoxides | 1 | 2001 | 389 | 0.040 |
Why?
|
| Capillaries | 1 | 2003 | 756 | 0.040 |
Why?
|
| Nitrates | 1 | 2001 | 260 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2000 | 198 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5952 | 0.040 |
Why?
|
| Pain | 1 | 1995 | 5100 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2906 | 0.040 |
Why?
|
| Epitopes | 2 | 1996 | 2526 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2011 | 3046 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1998 | 186 | 0.040 |
Why?
|
| Neurons | 2 | 2015 | 9518 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 1998 | 75 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 511 | 0.040 |
Why?
|
| Glycosylation | 1 | 2001 | 1100 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 540 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1514 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1996 | 283 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2019 | 199 | 0.040 |
Why?
|
| Enzyme Induction | 2 | 1996 | 455 | 0.040 |
Why?
|
| Calcimycin | 1 | 1998 | 214 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 2094 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2019 | 202 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 447 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2003 | 8120 | 0.030 |
Why?
|
| Palmitates | 1 | 1997 | 70 | 0.030 |
Why?
|
| RNA Interference | 1 | 2005 | 2830 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 174 | 0.030 |
Why?
|
| Peptides | 2 | 2003 | 4354 | 0.030 |
Why?
|
| Cysteine | 2 | 2005 | 897 | 0.030 |
Why?
|
| omega-N-Methylarginine | 2 | 1993 | 108 | 0.030 |
Why?
|
| Dystrophin | 1 | 1997 | 284 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1996 | 71 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 1083 | 0.030 |
Why?
|
| Sheep | 2 | 1996 | 1451 | 0.030 |
Why?
|
| Actin-Related Protein 3 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1997 | 426 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1994 | 421 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 96 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2016 | 46 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 316 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2015 | 63 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1996 | 1750 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2021 | 800 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2016 | 86 | 0.030 |
Why?
|
| Mutation | 4 | 2007 | 30211 | 0.030 |
Why?
|
| Methods | 1 | 1996 | 1066 | 0.030 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Sodium | 1 | 1980 | 1597 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 339 | 0.030 |
Why?
|
| Sodium Hypochlorite | 1 | 2015 | 31 | 0.030 |
Why?
|
| Research Personnel | 1 | 2020 | 589 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 849 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10470 | 0.030 |
Why?
|
| Triethylenemelamine | 1 | 1974 | 1 | 0.030 |
Why?
|
| Brain | 4 | 2006 | 27366 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2000 | 1461 | 0.030 |
Why?
|
| RNA, Transfer, Ser | 1 | 2014 | 7 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 610 | 0.030 |
Why?
|
| Aging | 2 | 2010 | 8744 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3612 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2857 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 931 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 247 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12165 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2015 | 612 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1731 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 1995 | 4351 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 701 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3007 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2016 | 5151 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1435 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 429 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3074 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 538 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2016 | 863 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1994 | 4618 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 219 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2020 | 1064 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 464 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9614 | 0.030 |
Why?
|
| Radioligand Assay | 3 | 1997 | 366 | 0.030 |
Why?
|
| Endothelins | 1 | 1992 | 127 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 757 | 0.030 |
Why?
|
| Selenoproteins | 1 | 2014 | 216 | 0.030 |
Why?
|
| Rodentia | 1 | 1994 | 262 | 0.020 |
Why?
|
| Cholesterol | 2 | 2013 | 2914 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1998 | 1216 | 0.020 |
Why?
|
| Binding, Competitive | 5 | 1992 | 1142 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 6211 | 0.020 |
Why?
|
| Adult | 4 | 2024 | 223583 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 1992 | 769 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 1993 | 213 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1996 | 1055 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 1996 | 651 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 832 | 0.020 |
Why?
|
| Estradiol | 1 | 1999 | 1951 | 0.020 |
Why?
|
| Hindlimb | 1 | 2014 | 516 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1225 | 0.020 |
Why?
|
| Mitogens | 1 | 1991 | 229 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 3601 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 775 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 1992 | 240 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2016 | 1207 | 0.020 |
Why?
|
| Selenium | 1 | 2014 | 418 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9252 | 0.020 |
Why?
|
| Homocysteine | 1 | 2014 | 637 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1992 | 562 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 10094 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 848 | 0.020 |
Why?
|
| Liposomes | 1 | 1994 | 790 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 1993 | 415 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 671 | 0.020 |
Why?
|
| Polymers | 1 | 1998 | 1627 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1679 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 413 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 557 | 0.020 |
Why?
|
| Microcirculation | 1 | 1995 | 1281 | 0.020 |
Why?
|
| Neuroglia | 1 | 2015 | 961 | 0.020 |
Why?
|
| Atropine | 2 | 2001 | 243 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 1065 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1989 | 289 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2299 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4205 | 0.020 |
Why?
|
| Drosophila | 1 | 2015 | 1513 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1974 | 1777 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2510 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3096 | 0.020 |
Why?
|
| Body Composition | 1 | 1996 | 2462 | 0.020 |
Why?
|
| Forecasting | 1 | 2016 | 2945 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1110 | 0.020 |
Why?
|
| Rabbits | 3 | 1998 | 4771 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1986 | 70 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Macrophages | 3 | 2005 | 5799 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1974 | 2614 | 0.020 |
Why?
|
| Lipopolysaccharides | 4 | 1995 | 2219 | 0.020 |
Why?
|
| Alprostadil | 2 | 1982 | 86 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1993 | 841 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2035 | 0.020 |
Why?
|
| Rhodopsin | 1 | 1986 | 202 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2298 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 460 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 2005 | 29 | 0.020 |
Why?
|
| Avidin | 1 | 2005 | 44 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2005 | 35 | 0.020 |
Why?
|
| Resorcinols | 1 | 2005 | 41 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 2005 | 170 | 0.020 |
Why?
|
| Dihydroergotoxine | 2 | 1984 | 21 | 0.020 |
Why?
|
| Alprenolol | 2 | 1982 | 8 | 0.010 |
Why?
|
| DNA Repair | 1 | 1974 | 2050 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 490 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2007 | 577 | 0.010 |
Why?
|
| Biotinylation | 1 | 2005 | 185 | 0.010 |
Why?
|
| Placenta | 1 | 1994 | 1725 | 0.010 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11930 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 11068 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 204 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1551 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 16723 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 10871 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1983 | 107 | 0.010 |
Why?
|
| Cytokines | 2 | 1996 | 7450 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1500 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2004 | 424 | 0.010 |
Why?
|
| Bone Density | 1 | 1996 | 3573 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1995 | 2521 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2800 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1984 | 2418 | 0.010 |
Why?
|
| Heme | 1 | 2005 | 316 | 0.010 |
Why?
|
| Erythrocyte Membrane | 2 | 1982 | 438 | 0.010 |
Why?
|
| Coronary Artery Bypass | 2 | 2003 | 2191 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2015 | 4215 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 525 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Infant | 2 | 2015 | 36534 | 0.010 |
Why?
|
| Sympatholytics | 1 | 2001 | 82 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 5772 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 577 | 0.010 |
Why?
|
| Firefly Luciferin | 1 | 2001 | 7 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 577 | 0.010 |
Why?
|
| Digitonin | 1 | 1981 | 25 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 2001 | 43 | 0.010 |
Why?
|
| Female | 6 | 2015 | 397113 | 0.010 |
Why?
|
| Octopamine | 1 | 2001 | 43 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2001 | 89 | 0.010 |
Why?
|
| Spin Trapping | 1 | 2001 | 4 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4351 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2001 | 71 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1322 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2004 | 507 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 2001 | 60 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2001 | 126 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2001 | 2258 | 0.010 |
Why?
|
| Triglycerides | 1 | 2008 | 2463 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1992 | 2663 | 0.010 |
Why?
|
| Zinc | 1 | 2005 | 677 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 840 | 0.010 |
Why?
|
| Peroxisomes | 1 | 2001 | 67 | 0.010 |
Why?
|
| Digoxin | 1 | 2001 | 246 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1992 | 2591 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2001 | 120 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 1134 | 0.010 |
Why?
|
| NADP | 1 | 2001 | 229 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 213 | 0.010 |
Why?
|
| Ouabain | 1 | 2000 | 246 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2000 | 315 | 0.010 |
Why?
|
| Propranolol | 1 | 2001 | 493 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
| Benzoates | 1 | 2001 | 213 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 714 | 0.010 |
Why?
|
| Gene Expression | 1 | 1992 | 7597 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2008 | 6429 | 0.010 |
Why?
|
| Cystatin C | 1 | 2000 | 272 | 0.010 |
Why?
|
| Adipose Tissue | 2 | 2008 | 3329 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8761 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2000 | 262 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1991 | 154 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1984 | 922 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2001 | 596 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2065 | 0.010 |
Why?
|
| Centrifugation, Isopycnic | 1 | 1997 | 8 | 0.010 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1997 | 19 | 0.010 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 1997 | 16 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2001 | 573 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 1266 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 542 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 74936 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1991 | 3929 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 135 | 0.010 |
Why?
|
| Genotype | 2 | 2001 | 13042 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 475 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 1009 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2001 | 981 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2487 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1778 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3798 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 2493 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29979 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 2618 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 1168 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1992 | 898 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 662 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 1880 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2001 | 1793 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 316 | 0.010 |
Why?
|
| Quality of Life | 2 | 1996 | 13489 | 0.010 |
Why?
|
| Thymidine | 1 | 1974 | 297 | 0.010 |
Why?
|
| Haplotypes | 1 | 2000 | 2722 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1712 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171446 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2748 | 0.010 |
Why?
|
| Cell Communication | 1 | 2001 | 1660 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 299 | 0.010 |
Why?
|
| Autoradiography | 1 | 1974 | 727 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3347 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1698 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42665 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 13091 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1997 | 1165 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 521 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1991 | 98 | 0.010 |
Why?
|
| Motor Activity | 1 | 2001 | 2711 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1621 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5902 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2415 | 0.010 |
Why?
|
| Colon | 1 | 1998 | 1800 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3841 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4248 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 1607 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1084 | 0.010 |
Why?
|
| Renal Artery | 1 | 1991 | 354 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14718 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 605 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4269 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 6894 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 617 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2421 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 600 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 1942 | 0.000 |
Why?
|
| Young Adult | 1 | 2015 | 60048 | 0.000 |
Why?
|
| Risk | 1 | 2000 | 9609 | 0.000 |
Why?
|
| Odds Ratio | 1 | 2000 | 9666 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6411 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 548 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 1996 | 0.000 |
Why?
|
| Child | 1 | 2015 | 80906 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 89155 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6119 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1987 | 432 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1305 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1996 | 2589 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13289 | 0.000 |
Why?
|
| Lipids | 1 | 1996 | 3342 | 0.000 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 1984 | 25 | 0.000 |
Why?
|
| Turkeys | 1 | 1984 | 44 | 0.000 |
Why?
|
| Middle Aged | 3 | 2000 | 223422 | 0.000 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1984 | 73 | 0.000 |
Why?
|
| Bucladesine | 1 | 1984 | 118 | 0.000 |
Why?
|
| Mesocricetus | 1 | 1984 | 256 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1974 | 2935 | 0.000 |
Why?
|
| Fluorides | 1 | 1984 | 134 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2932 | 0.000 |
Why?
|
| Educational Status | 1 | 1991 | 2515 | 0.000 |
Why?
|
| Anura | 1 | 1982 | 79 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2000 | 22287 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6231 | 0.000 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 619 | 0.000 |
Why?
|
| Prazosin | 1 | 1982 | 95 | 0.000 |
Why?
|
| Orthopedics | 1 | 1991 | 906 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3780 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4978 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1981 | 8 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1987 | 2602 | 0.000 |
Why?
|
| Ranidae | 1 | 1981 | 32 | 0.000 |
Why?
|
| Phosphorylases | 1 | 1980 | 17 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 170 | 0.000 |
Why?
|
| Exercise | 1 | 1996 | 5955 | 0.000 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1980 | 177 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 18062 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1991 | 9384 | 0.000 |
Why?
|
| United States | 1 | 2001 | 73027 | 0.000 |
Why?
|